Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

Abstract

Deletion of the long arm of chromosome 20 represents the most common chromosomal abnormality associated with the myeloproliferative disorders (MPDs) and is also found in other myeloid malignancies including myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Previous studies have identified a common deleted region (CDR) spanning approximately 8 Mb. We have now used G-banding, FISH or microsatellite PCR to analyse 113 patients with a 20q deletion associated with a myeloid malignancy. Our results define a new MPD CDR of 2.7 Mb, an MDS/AML CDR of 2.6 Mb and a combined ‘myeloid’ CDR of 1.7 Mb. We have also constructed the most detailed physical map of this region to date – a bacterial clone map spanning 5 Mb of the chromosome which contains 456 bacterial clones and 202 DNA markers. Fifty-one expressed sequences were localized within this contig of which 37 lie within the MPD CDR and 20 within the MDS/AML CDR. Of the 16 expressed sequences (six genes and 10 unique ESTs) within the ‘myeloid’ CDR, five were expressed in both normal bone marrow and purified CD34 positive cells. These data identify a set of genes which are both positional and expression candidates for the target gene(s) on 20q.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3
Figure 2
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ahuja HG, Felix CA and Aplan PD. . 1999 Blood 94: 3258–3261.

  • Altschul SF, Gish W, Miller W, Meyers EW and Lipman DJ. . 1990 J. Mol. Biol. 215: 403–410.

  • Asimakopoulos FA, Gilbert JGR, Aldred MA, Pearson TC and Green AR. . 1996a Blood 88: 2690–2698.

  • Asimakopoulos FA, Holloway TL, Nacheva EP, Scott MA, Fenaux P and Green AR. . 1996b Blood 87: 1561–1570.

  • Asimakopoulos FA, White NJ, Nacheva E and Green AR. . 1994 Blood 84: 3086–3094.

  • Bench AJ, Aldred MA, Humphray SJ, Champion KM, Gilbert JGR, Asimakopoulos FA, Deloukas P, Gwilliam R, Bentley DR and Green AR. . 1998a Genomics 49: 351–362.

  • Bench AJ, Nacheva EP, Champion KM and Green AR. . 1998b Myeloproliferative Disorders, Green AR and Pearson TC (eds). Baillière Tindall: London, UK pp.819–848.

  • Bentley DR, Todd C, Collins J, Holland J, Dunham I, Hassock S, Bankier A and Giannelli F. . 1992 Genomics 12: 534–541.

  • Bernardi G. . 1993 Gene 135: 57–66.

  • Bonnet D and Dick JE. . 1997 Nat. Med. 3: 730–737.

  • Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M, Birren BB, Browne J, Butler A, Castle AB, Chiannilkulchai N, Clee C, Day PJ, Dehejia A, Dibling T, Drouot N, Duprat S, Fizames C and Bentley DR. . 1998 Science 282: 744–746.

  • Dewald GW, Schad CR, Lilla VC and Jalal SM. . 1993 Cancer Genet. Cytogenet. 68: 60–69.

  • Fenaux P, Morel P and Lai JL. . 1996 Semin. Hematol. 33: 127–138.

  • Fields C, Adams MD, White O and Venter JC. . 1994 Nat. Genet. 7: 345–346.

  • Gregory SG, Howell GR and Bentley DR. . 1997 Genome Res. 7: 1162–1168.

  • Heim S and Mitelman F. . 1992 Cancer 70: 1701–1709.

  • Hollings PE. . 1994 Genes Chrom. Cancer 11: 21–28.

  • Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA and de Jong PJ. . 1994 Nat. Genet. 6: 84–89.

  • Kobayashi T, Deak M, Morrice N and Cohen P. . 1999 Biochem. J. 344: 189–197.

  • Koga H, Matsui S, Hirota T, Takebayashi S, Okumura K and Saya H. . 1999 Oncogene 18: 3799–3809.

  • Kralovics R and Prchal JT. . 1998 Myeloproliferative Disorders. Green AR and Pearson TC. (eds). Baillière Tindall: London, UK pp. 803–818.

  • Kritis AA, Argyrokastritis A, Moschonas NK, Power S, Katrakili N, Zannis VI, Cereghini S and Talianidis I. . 1996 Gene 173: 275–280.

  • Le Beau MM, Westbrook CA, Diaz MO and Rowley JD. . 1985 Proc. Natl. Acad. Sci. USA 82: 6692–6696.

  • Lennon G, Auffray C, Polymeropoulos M and Soares MB. . 1996 Genomics 33: 151–152.

  • Mitelman F. . 1995 Catalog of Chromosome Aberrations in Cancer. Wiley-Liss, New York.

  • Mitelman F, Mertens F and Johansson B. . 1997 Nat. Genet. 15: 417–474.

  • Morris CM, Honeybone LM, Hollings PE and Fitzgerald PH. . 1989 Blood 74: 1768–1773.

  • Nacheva E, Grace C, Holloway TL and Green AR. . 1995a Cancer Genet. Cytogenet. 82: 9–16.

  • Nacheva E, Holloway T, Carter N, Grace C, White N and Green AR. . 1995b Cancer Genet. Cytogenet. 80: 87–94.

  • Osoegawa K, Woon PY, Zhao B, Frengen E, Tateno M, Catanese JJ and de Jong PJ. . 1998 Genomics 52: 1–8.

  • Ross MT and Langford CF. . 1997 Genome Mapping, Dear PH . (ed.). IRL Press: Oxford, UK pp. 165–184.

  • Roulston D, Espinosa III R, Stoffel M, Bell GI and Le Beau MM. . 1993 Blood 82: 3424–3429.

  • Rozen S and Skaletsky HJ. . 1998 http://www-genome.wi.mit.edu/genome_software/other/primer3.html.

  • Saville MK and Watson RJ. . 1998 Adv. Cancer Res. 72: 109–140.

  • Screaton GR, Cáceres JF, Mayeda A, Bell MV, Plebanski M, Jackson DG, Bell JI and Krainer AR. . 1995 EMBO J. 14: 4336–4349.

  • Soderlund C, Longden I and Mott R. . 1997 Comput. Appl. Biosci. 13: 523–535.

  • Stoffel M, Le Beau MM, Espinosa III R, Bohlander SF, Le Paslier D, Cohen D, Xiang KS, Cox NJ, Fajans SS and Bell GI. . 1996 Proc. Natl. Acad. Sci. USA 93: 3937–3941.

  • Wang PW, Eisenbart JD, Cordes SP, Barsh GS, Stoffel M and Le Beau MM. . 1999 Genomics 59: 275–281.

  • Wang PW, Iannantuoni K, Davis EM, Espinosa III R, Stoffel M and Le Beau MM. . 1998 Genes Chrom. Cancer 21: 75–81.

  • White NJ, Nacheva E, Asimakopoulos FA, Bloxham D, Paul B and Green AR. . 1994 Blood 83: 2809–2816.

  • Williams GW, Woollard PM and Hingamp P. . 1998 http://www.hgmp.mrc.ac.uk/NIX/

Download references

Acknowledgements

We thank the following cytogeneticists and clinicians for sending us patient samples: Profs P Fenaux (Lille, France), O Haas (Vienna, Austria) and J Prchal (Birmingham, AL, USA) and Drs M Abela (Gateshead, UK), E Blennow (Stockholm, Sweden), A Carroll (Birmingham, AL, USA), JA Copplestone (Plymouth, UK), W Finley (Birmingham, AL, USA), G Lucas (Manchester, UK), K Michalova (Prague, Czech Republic), S Raynaud (Nice, France), J Reilly (Sheffield, UK), A Semple (Epsom, UK) and I Wlodarska (Leuven, Belgium). The UKCCG laboratories participating in this study were as follows: the Department of Human Genetics, University of Newcastle upon Tyne (Newcastle, UK); the Cytogenetics Laboratory, Department of Haematology, Royal Free Hospital (London, UK); the Northern Ireland Regional Genetics Centre, Belfast City Hospital (Belfast, UK); the Cytogenetics Laboratory, Department of Clinical Haematology, University College Hospital (London, UK) and the Oxford Medical Genetics Laboratories, The Churchill Hospital (Oxford, UK). We thank Drs Jenny Craig, Mike Scott and Kevin Jestice and Ray Hicks for assistance with isolation of CD34 positive cells. This work was supported by the Leukaemia Research Fund, The Medical Research Council and The Wellcome Trust.

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bench, A., Nacheva, E., Hood, T. et al. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. Oncogene 19, 3902–3913 (2000). https://doi.org/10.1038/sj.onc.1203728

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203728

Keywords

This article is cited by

Search

Quick links